Complicated Withdrawal Phenomena During Benzodiazepine Cessation in Older Adults.
Complicated Withdrawal Phenomena During Benzodiazepine Cessation in Older Adults. J Am Osteopath Assoc. 2019 May 01;119(5):327-331 Authors: Reeves RR, Kamal A Abstract The cause of prolonged or recurrent symptoms following the cessation of long-term benzodiazepine use is proposed to be related to downregulation and allosteric decoupling of the γ-aminobutyric acid/benzodiazepine receptor complex. This case series describes 2 patients with prolonged (>2 weeks) recurrent complications during attempted tapering of benzodiazepine doses after long-term treatment. Excited catatonia developed in a 90-year-old woman, and prolonged delirium developed in a 69-year-old woman. Both patients showed improvement of symptoms after resumption of higher doses of benzodiazepine treatment and recurrence of symptoms when the dose was again lowered. Caution should be exercised regarding the long-term use of benzodiazepines in older adults (aged ≥65 years). Tapering of benzodiazepines in older patients after long-term treatment may require slow decreases in dose over long periods. Psychotherapeutic interventions, such as brief cognitive therapy with psychoeducation and motivational enhancement, and osteopathic manipulative treatment to decrease paravertebral muscle tension may be beneficial during the tapering process. PMID: 31034071 [PubMed - in process]
Now that we’re in the middle of a pandemic, more people than ever are experiencing anxiety, especially those who struggled with mental health issues before COVID-19. And to make things even worse, many of our coping mechanisms, like going to the gym or hanging out with friends, have been taken away. In today’s show, our host, Gabe Howard, talks with Dr. Jasleen Chhatwal, who helps explain why so many people are having anxiety symptoms and what we can do about it. We want to hear from you — Please fill out our listener survey by clicking the graphic below! SUBSCRIBE &REVIEW Guest informatio...
ConclusionAt this point, the CCT seems not suitable to enhance cognitive resilience factors in older non-depressed individuals. However, there is need for more research on possible moderators of the effects, as well as larger-scale studies with longer follow-up measurements.
ConclusionsVarious types of CFT are differentially related to psychological symptoms with downward CFT facilitating posttraumatic growth in some individuals. Implications for psychological interventions are discussed.
ConclusionsFindings illuminate the clinical processes through which socially traumatic memories in SAD may be updated in IR by guiding patients to fulfill their needs and promote improved emotional health.
CONCLUSION: The treatment of PTSD by cognitive-behavioural therapy adapted to elderly people without cognitive impairment, or with mild cognitive or memory disorders, allows for a lasting disappearance of symptoms and an improvement in quality of life. PMID: 32928534 [PubMed - as supplied by publisher]
ConclusionsThe results strengthen subjective knowledge gain as a candidate for use as a predictor of treatment effects in ICBT-i.
ConclusionsMaladaptive metacognitive beliefs are associated with residual anxiety in remitted patients with BD. Treatments that specifically target maladaptive metacognitive beliefs may have potential to reduce anxiety in remitted phases of BD and enhance patients’ functional recovery and quality of life.
CONCLUSIONS: Patients' fatigue, physical functioning and social adjustment all significantly improved following cognitive behavioural therapy for chronic fatigue syndrome in a naturalistic outpatient setting. These findings support the growing evidence from previous randomised control trials and suggest that cognitive behavioural therapy could be an effective treatment in routine treatment settings. PMID: 32930040 [PubMed - as supplied by publisher]
ConclusionsThe MAQ is reliable and has a meaningful scale structure, may usefully distinguish both quality versus quantity and formal versus informal MBP, and is sensitive to variations in MBP and does not solely measure trait mindfulness.
ConclusionsSpecific symptoms can function as bridges between depression, anxiety and stress, which is clinically relevant on top of being theoretically important.